Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The core and extension studies assessed the safety and efficacy of aliskiren when added to
optimized standard therapy in patients that have had a high risk acute myocardial infarction
(heart attack).